Cell & Gene Therapy Leaders
Meet our cell and gene therapy leaders with deep experience ready to support your cutting-edge innovation
-
Global laboratory teams experienced in cell and gene therapy development from preclinical discovery to CDx development and commercialization
-
A multi-disciplinary team of scientific, operational leads and program managers to support critical milestones along your entire development journey
-
Strategic collaborations with leading industry partners to provide a coordinated and flexible response to your program needs
Personal attention, global capabilities
Based on your program needs, we streamline your efforts and help you advance quickly with:
Dedicated PhD-level scientists committed to your mission - We embrace your unique culture and business, striving to be the flexible partner you need to make your job and decisions easier.
Solutions tailored to your requirements - We align our support with your goals to help you rapidly progress to IND/CTA and beyond.
A network of global resources – Our global network includes data, logistics, laboratory capabilities and program management throughout the United States, Europe, Singapore and China with an infrastructure that can scale with your program.
Areas of expertise
Our cell and gene therapy team has executive-level oversight and subject matter expertise from the following functional areas:
Meet key cell and gene therapy leaders
Learn more about the experience of team members who can help you apply best practices for your candidate selection, IND/CTA-enabling programs (preclinical proof of concept), biomarker strategy and CDx commercialization.
Maryland Franklin, PhD
Vice President and Enterprise Head of Cell & Gene Therapy
- More than 20 years of experience in preclinical and early clinical development spanning therapeutic types including small molecules, antibodies, and cell and gene therapies
- Over eight years of CRO experience in preclinical and translational services for oncology, immuno-oncology and cell therapy
- Expertise in driving strategic vision, thought leadership, and internal and external collaborations
- PhD in medical genetics researching cancer gene therapy
Akanksha Gupta, PhD
Executive Director, Enterprise Cell & Gene Therapy
- More than 15 years of pharmaceutical industry experience in drug development
- Specialized expertise in providing strategic leadership in varied phases of drug discovery and development phases, from preclinical through to Phase III, including precision medicine approaches centered around clinical biomarker and CDx development
Brian McIntosh, PhD
Lead, Cell & Gene Therapy/Safety Assessment/Toxicology
- More than 25 combined years of experience in industry and academia
- Specialized expertise in cancer biology, immunology, genetic engineering, toxicology, developmental stem cell biology and IND-enabling support for cell and gene therapies
- Received PhD in cancer biology from McArdle Laboratory at the University of Wisconsin-Madison and performed postdoctoral work with stem cell biologist Jamie Thomson
Scott Wise, MS
Head of Preclinical Oncology
- More than 30 years of research experience in oncology drug discovery
- Directed biological discovery of multiple oncology programs, several which progressed to the clinic and one gaining full approval for treatment of GIST cancers
- Authored 21 publications and numerous abstracts and presentations
- Expanded in vitro assays and services in Preclinical Oncology for Labcorp
- 1
- 2
- 3
- 4
LABCORP CELL AND GENE THERAPY SOLUTIONS